Heart Disease News and Research

Latest Heart Disease News and Research

Amgen reports $3,816 million for 2010 third quarter revenue

Amgen reported revenue unchanged for the third quarter of 2010 at $3,816 million versus $3,812 million for the third quarter of 2009.

26 Oct 2010

Alzheimer’s risk raised 157% with smoking: Study

A Kaiser Permanente study reported this Monday that heavy smoking in midlife more than doubles the odds of developing Alzheimer's disease. This study is one of the first of its kind to examine the long-term consequences of heavy smoking on Alzheimer's disease and vascular dementia explained the study's principal investigator, Rachel Whitmer, a research scientist with Kaiser Permanente in Oakland. The research is published in the Archives of Internal Medicine.

25 Oct 2010

Helicos names Illumina and Life Technologies as additional defendants in lawsuit against Pacific Biosciences

Helicos BioSciences Corporation announced today that it has amended its lawsuit against Pacific Biosciences of California, Inc. for patent infringement by naming Illumina, Inc. and Life Technologies Corporation as additional defendants.

From Illumina, Inc. 25 Oct 2010

Repros commences randomization in Androxal Phase II study in T2DM men with low testosterone

Repros Therapeutics Inc. today announced it has commenced randomization of subjects into its Phase II Androxal® study in the treatment of type 2 diabetes (T2DM) in men with low testosterone. Low testosterone and T2DM are co-morbid conditions in a significant number of men. The study is being conducted at nine sites across the US including both academic and private practices and will enroll up to 150 patients.

25 Oct 2010

Daily dose of whole body vibration reduces bone density loss

A daily dose of whole body vibration may help reduce the usual bone density loss that occurs with age, Medical College of Georgia researchers report.

25 Oct 2010

CryoLife commences European distribution of PerClot polysaccharide hemostatic agent

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has begun European distribution of PerClot®, a novel polysaccharide hemostatic agent used to control bleeding during surgical procedures or following traumatic injuries.

25 Oct 2010

Marathon running without proper training can damage the heart

Is running a marathon good for you or can it damage the heart?

25 Oct 2010

Intensive population management program reduces risk of death, health care costs

A new study from Kaiser Permanente Colorado is one of the first to show that an intensive population management program that matches heart disease patients to personal nurses and clinical pharmacy specialists not only reduces the risk of death but reduces health care costs as well.

25 Oct 2010

NeedleTech increases production area with new 73,000-square foot manufacturing facility

U.S. Congressman James McGovern, State Representative Elizabeth Poirier and local dignitaries joined Theragenics Corporation executives in ribbon cutting ceremonies on October 15 for a new 73,000-square foot manufacturing facility for the company's subsidiary, NeedleTech Products. The new facility increases NeedleTech's production area by 30% or 20,000 square feet, allowing the company to consolidate two separate older facilities into one location. The new building will allow NeedleTech to expand operations, increase R&D and offer more services to its customers.

25 Oct 2010

Barriers for female heart patients entering cardiac rehab

Cardiac rehabilitation is considered the pillar of preventing a second cardiac event yet those who stand to benefit the most - women and the elderly − are often missing out, Dr. Billie Jean Martin told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

25 Oct 2010

Non communicable diseases will cost India USD237 billion during 2006-15

Health experts participating at a roundtable organised by India Health Progress(IHP) on economic and social impact of non-communicable diseases in India are of the opinion that a concerted effort is required to address the growing burden.

25 Oct 2010

Childhood allergies and asthma linked to development in the womb

A child's chances of developing allergies or wheezing is related to how he or she grew at vital stages in the womb, according to scientists from the University of Southampton.

25 Oct 2010

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Summaries of a number of new Canadian Cardiovascular Society guidelines and position statements offering the most up to date information to support clinicians in practicing evidence-based medicine were released at the Canadian Cardiovascular Congress 2010 this week.

25 Oct 2010

Neptune launches Onemia medical food

Neptune Technologies & Bioressources Inc. enters the pharmaceutical market with the launch of Onemia™, the first medical food of Neptune's subsidiary Acasti Pharma Inc.. Only two years since its foundation, Acasti has completed the development and launch of "Onemia™" on October 21, 2010 at the Cardiometabolic Health Congress meeting in Boston.

25 Oct 2010

Sorin announces full and final settlement of Department of Justice's Ela Medical investigation

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today that it has concluded a full and final settlement of the United States Department of Justice investigation into sales and marketing practices of its subsidiary Ela Medical, Inc. and of former independent sales representatives. Tentative settlement had been previously announced by the Group on March 12th, 2010.

25 Oct 2010

CARTaGENE database meets 20k participant milestone

This week, the last questionnaire was filled out and the final vial of blood was drawn, closing CARTaGENE's first ambitious goal of collecting samples and data from 20 000 Quebecers.

25 Oct 2010

Gene therapy may reverse pulmonary hypertension

A Heart and Stroke Foundation researcher has discovered what could be the first truly effective breakthrough in the diagnosis and treatment of pulmonary hypertension, a devastating, life-threatening condition which results in an enlargement of the heart.

25 Oct 2010

New gene therapy product reduces plasma cholesterol levels

Amsterdam Molecular Therapeutics (AMT) Holding N.V. a leader in the development of gene based therapies, today announced that its gene therapy product incorporating siRNA sequences into microRNA scaffolds to silence Apolipoprotein B100 (AAV-miApoB) was able to significantly lower plasma cholesterol levels in vivo over a period of 18 weeks. These preliminary results suggest that this approach could lead to a treatment for high cholesterol in humans

25 Oct 2010

Experts identify efficient way to increase minority access to colorectal cancer screening

Minority patients have a significantly decreased survival from colon cancer compared to white patients, most often as a result of a late diagnosis. To help address this problem, a team of healthcare professionals at Memorial Sloan-Kettering Cancer Center has identified an efficient way to increase minority access to lifesaving colorectal cancer screening (CRCS) in communities where multiple barriers to preventive care exist.

25 Oct 2010

Sleep disturbances increase risk of work disability

Sleep disturbances increase the risk of work disability and may slow the return to work process. This is especially true in cases where work disability is due to mental disorders or musculoskeletal diseases. These results come from a recent study conducted by the Finnish Institute of Occupational Health in collaboration with the universities of Turku and London.

25 Oct 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Amgen reports $3,816 million for 2010 third quarter revenue

Alzheimer’s risk raised 157% with smoking: Study

Helicos names Illumina and Life Technologies as additional defendants in lawsuit against Pacific Biosciences

Repros commences randomization in Androxal Phase II study in T2DM men with low testosterone

Daily dose of whole body vibration reduces bone density loss

CryoLife commences European distribution of PerClot polysaccharide hemostatic agent

Marathon running without proper training can damage the heart

Intensive population management program reduces risk of death, health care costs

NeedleTech increases production area with new 73,000-square foot manufacturing facility

Barriers for female heart patients entering cardiac rehab

Non communicable diseases will cost India USD237 billion during 2006-15

Childhood allergies and asthma linked to development in the womb

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Neptune launches Onemia medical food

Sorin announces full and final settlement of Department of Justice's Ela Medical investigation

CARTaGENE database meets 20k participant milestone

Gene therapy may reverse pulmonary hypertension

New gene therapy product reduces plasma cholesterol levels

Experts identify efficient way to increase minority access to colorectal cancer screening

Sleep disturbances increase risk of work disability

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Heart Disease News and Research

Latest Heart Disease News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in